EBR Systems Q1 preliminary revenue $2.25-$2.36M; commercial cases double QoQ

EBR Systems, Inc.

2026-Q1 EPS reported -$0.38 revenue$2,362,000

Preliminary unaudited Q1 2026 revenue $2.25M-$2.36M; financial close not yet complete.
41 WiSE implants in Q1 2026, more than double Q4 2025; cumulative 71 commercial implants.
Added 16 purchase agreements (total 37) and 22 trained physicians (total 55) in Q1.
1-for-10 reverse stock split effective April 1; CDI conversion ratio changed to 10:1.
Management cites strong commercial momentum, expanding site readiness and physician training.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

EBR Systems, Inc. reported the first quarter ended March 31, 2026 results: revenue US$2.25M to US$2.36M.

Period: the first quarter ended March 31, 2026
Revenue: US$2.25M to US$2.36M
Result: preliminary results

Exact text from the filing

in 41 commercial patients during the quarter, bringing total implants across the pilot phase and Limited Market Release to 71 · EBR expects to report revenue in the range of US$2.25M to US$2.36M for Q1 2026, based on preliminary unaudited quarter-end results and subject to quarter-end closing adjustments · The Limited Market Release continued to advance in

View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

EBR Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-26-004488

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.